{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:19Z","timestamp":1792791499733,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009358","name":"Duchenne Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ymthe.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T16:07:19Z","timestamp":1752768439000},"page":"5099-5117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies"],"prefix":"10.1016","volume":"33","author":[{"given":"Karim","family":"Azzag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Kiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin","family":"Sumstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Kadidlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Crist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ahlquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura L.","family":"Hocum Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Shappa Faustich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davis","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parthasarathy","family":"Rangarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunkee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Flory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Bushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabarinathan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter B.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kyba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-1118","authenticated-orcid":false,"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.07.007_bib1","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","article-title":"The muscular dystrophies","volume":"359","author":"Emery","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.07.007_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: The protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.07.007_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00028.2001","article-title":"Function and Genetics of Dystrophin and Dystrophin-Related Proteins in Muscle","volume":"82","author":"Blake","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib4","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0009922810378738","article-title":"Review of Duchenne Muscular Dystrophy (DMD) for the Pediatricians in the Community","volume":"49","author":"Verma","year":"2010","journal-title":"Clin. Pediatr."},{"key":"10.1016\/j.ymthe.2025.07.007_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib6","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1126\/science.1233074","article-title":"A Genetic Intervention Stands a Skip Away from Clinical Tests","volume":"338","author":"Chamberlain","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.07.007_bib7","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.07.007_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2025.07.007_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.07.007_bib11","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.stemcr.2023.05.003","article-title":"Country-specific regulation and international standardization of cell-based therapeutic products derived from pluripotent stem cells","volume":"18","author":"Hirai","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12015-021-10262-3","article-title":"Review of the Current Trends in Clinical Trials Involving Induced Pluripotent Stem Cells","volume":"18","author":"Kim","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib13","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent Stem Cell-Based Cell Therapy\u2014Promise and Challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.07.007_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nm1705","article-title":"Functional skeletal muscle regeneration from differentiating embryonic stem cells","volume":"14","author":"Darabi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s12015-011-9258-2","article-title":"Functional Myogenic Engraftment from Mouse iPS Cells","volume":"7","author":"Darabi","year":"2011","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/stem.625","article-title":"Assessment of the Myogenic Stem Cell Compartment Following Transplantation of Pax3\/Pax7 -Induced Embryonic Stem Cell-Derived Progenitors","volume":"29","author":"Darabi","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib17","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2025.07.007_bib18","article-title":"Engraftment of ES-Derived Myogenic Progenitors in a Severe Mouse Model of Muscular Dystrophy","volume":"10","author":"Filareto","year":"2012","journal-title":"J. Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2025.07.007_bib19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymthe.2025.07.007_bib20","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","article-title":"PAX7 Targets, CD54, Integrin \u03b19\u03b21, and SDC2, Allow Isolation of Human ESC\/iPSC-Derived Myogenic Progenitors","volume":"19","author":"Magli","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib21","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.ymthe.2019.08.011","article-title":"Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy","volume":"27","author":"Selvaraj","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.007_bib22","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/cells13110972","article-title":"A Novel CRISPR-Cas9 Strategy to Target DYSTROPHIN Mutations Downstream of Exon 44 in Patient-Specific DMD iPSCs","volume":"13","author":"Dhoke","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41536-024-00360-4","article-title":"The adult environment promotes the transcriptional maturation of human iPSC-derived muscle grafts","volume":"9","author":"Crist","year":"2024","journal-title":"NPJ Regen. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-020-00228-3","article-title":"Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I","volume":"10","author":"Azzag","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.ymthe.2025.07.007_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","article-title":"CGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications","volume":"5","author":"Baghbaderani","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib26","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2017-04-777136","article-title":"Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult","volume":"130","author":"Morris","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.07.007_bib27","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1182\/blood.2019002350","article-title":"Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs","volume":"135","author":"Six","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.ymthe.2025.07.007_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41591-021-01554-9","article-title":"Lentiviral globin gene therapy with reduced-intensity conditioning in adults with \u03b2-thalassemia: a phase 1 trial","volume":"28","author":"Boulad","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","article-title":"Lentiviral gene therapy for X-linked chronic granulomatous disease","volume":"26","author":"Kohn","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature07384","article-title":"Self-renewal and expansion of single transplanted muscle stem cells","volume":"456","author":"Sacco","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.007_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147198","article-title":"Comparative Study of Injury Models for Studying Muscle Regeneration in Mice","volume":"11","author":"Hardy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2025.07.007_bib32","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/stem.1402","article-title":"A New Immuno-Dystrophin-Deficient Model, the NSG-mdx 4Cv Mouse, Provides Evidence for Functional Improvement Following Allogeneic Satellite Cell Transplantation","volume":"31","author":"Arpke","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mus.880140108","article-title":"X-Irradiation improves mdx mouse muscle as a model of myofiber loss in DMD","volume":"14","author":"Wakeford","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.007_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/mus.880180209","article-title":"Radiation inhibition of mdx mouse muscle regeneration: Dose and age factors","volume":"18","author":"Quinlan","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.007_bib35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/(SICI)1097-4598(199708)20:8<1016::AID-MUS12>3.0.CO;2-T","article-title":"Regeneration-blocked mdx muscle: in vivo model for testing treatments","volume":"20","author":"Quinlan","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.007_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-510X(93)90224-M","article-title":"Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice","volume":"115","author":"Morgan","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymthe.2025.07.007_bib37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-4598(199602)19:2<132::AID-MUS2>3.0.CO;2-F","article-title":"Yields of muscle from myogenic cells implanted into young and old mdx hosts","volume":"19","author":"Morgan","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.007_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.scr.2014.10.007","article-title":"Satellite cells from dystrophic muscle retain regenerative capacity","volume":"14","author":"Boldrin","year":"2015","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.ymthe.2025.07.007_bib39","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI63992","article-title":"Human satellite cells have regenerative capacity and are genetically manipulable","volume":"124","author":"Marg","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.07.007_bib40","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"Chan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2025.07.007_bib41","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/stem.1158","article-title":"Donor Satellite Cell Engraftment Is SignificantlyAugmented When the Host Niche Is Preserved and Endogenous Satellite Cells Are Incapacitated","volume":"30","author":"Boldrin","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/0300985819882631","article-title":"Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma\/Leukemia in NSG Mice","volume":"57","author":"Tillman","year":"2020","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib43","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/cells12081147","article-title":"Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem Cells","volume":"12","author":"Baik","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-021-02395-6","article-title":"Submacular integration of hESC-RPE monolayer xenografts in a surgical non-human primate model","volume":"12","author":"Liu","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ymthe.2025.07.007_bib45","doi-asserted-by":"crossref","first-page":"e2400072","DOI":"10.1002\/bies.202400072","article-title":"iPS cell therapy 2.0: Preparing for next-generation regenerative medicine","volume":"46","author":"Hui","year":"2024","journal-title":"Bioessays."},{"key":"10.1016\/j.ymthe.2025.07.007_bib46","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.880150504","article-title":"Human myoblast transplantation: Preliminary results of 4 cases","volume":"15","author":"Huard","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.007_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410340105","article-title":"Myoblast transfer in duchenne muscular dystrophy","volume":"34","author":"Karpati","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib48","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast Transfer in the Treatment of Duchenne\u2019s Muscular Dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib49","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0140-6736(90)91628-N","article-title":"Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy","volume":"336","author":"Law","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ymthe.2025.07.007_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/356435a0","article-title":"Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation","volume":"356","author":"Gussoni","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2025.07.007_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096368979300200203","article-title":"Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular Dystrophy","volume":"2","author":"Tremblay","year":"1993","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2025.07.007_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0963689792001002-305","article-title":"Feasibility, Safety, and Efficacy of Myoblast Transfer Therapy on Duchenne Muscular Dystrophy Boys","volume":"1","author":"Law","year":"1992","journal-title":"Cell Transpl."},{"key":"10.1016\/j.ymthe.2025.07.007_bib53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nmd.2006.10.003","article-title":"First test of a \u201chigh-density injection\u201d protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up","volume":"17","author":"Skuk","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.07.007_bib54","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.jnen.0000218443.45782.81","article-title":"Dystrophin Expression in Muscles of Duchenne Muscular Dystrophy Patients After High-Density Injections of Normal Myogenic Cells","volume":"65","author":"Skuk","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib55","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ymthe.2003.11.023","article-title":"Dystrophin Expression in Myofibers of Duchenne Muscular Dystrophy Patients Following Intramuscular Injections of Normal Myogenic Cells","volume":"9","author":"Skuk","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.007_bib56","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA -matched donor mesoangioblasts in Duchenne muscular dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.07.007_bib57","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3390\/cells13070596","article-title":"Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy","volume":"13","author":"Sun","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib58","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A Third-Generation Lentivirus Vector with a Conditional Packaging System","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib59","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.07.007_bib60","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2025.07.007_bib61","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1172\/JCI67930","article-title":"\u03b2-globin gene transfer to human bone marrow for sickle cell disease","volume":"123","author":"Romero","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2025.07.007_bib62","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.omtm.2019.08.014","article-title":"Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID","volume":"15","author":"Charrier","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101323","article-title":"Lentiviral vectors for precise expression to treat X-linked lymphoproliferative disease","volume":"32","author":"Ayoub","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib64","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4252\/wjsc.v7.i1.174","article-title":"Advances and challenges in the differentiation of pluripotent stem cells into pancreatic \u03b2 cells","volume":"7","author":"Abdelalim","year":"2015","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.ymthe.2025.07.007_bib65","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human Embryonic Stem Cell-Derived Cardiomyocytes Regenerate the Infarcted Pig Heart but Induce Ventricular Tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib66","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.stemcr.2022.12.010","article-title":"Dual inhibition of MAPK and PI3K\/AKT pathways enhances maturation of human iPSC-derived cardiomyocytes","volume":"18","author":"Garay","year":"2023","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymthe.2025.07.007_bib67","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.47970","article-title":"Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes","volume":"8","author":"Selvaraj","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ymthe.2025.07.007_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.omtm.2016.11.002","article-title":"INSPIIRED: A Pipeline for Quantitative Analysis of Sites of New DNA Integration in Cellular Genomes","volume":"4","author":"Sherman","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib69","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.omtm.2016.11.003","article-title":"INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site Distributions","volume":"4","author":"Berry","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymthe.2025.07.007_bib70","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/bioinformatics\/bts004","article-title":"Estimating abundances of retroviral insertion sites from DNA fragment length data","volume":"28","author":"Berry","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ymthe.2025.07.007_bib71","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.ymthe.2025.07.007_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0684.2009.00340.x","article-title":"A novel alternative placement site and technique for totally implantable vascular access ports in non-human primates","volume":"38","author":"Graham","year":"2009","journal-title":"J. Med. Primatol."},{"key":"10.1016\/j.ymthe.2025.07.007_bib73","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/08941939.2018.1536178","article-title":"Long-Term Management of Vascular Access Ports in Nonhuman Primates Used in Preclinical Efficacy and Tolerability Studies","volume":"33","author":"Mutch","year":"2020","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.ymthe.2025.07.007_bib74","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3390\/surgeries4030044","article-title":"Indwelling Vascular Access Ports: Application, Advantages, and Management in Nonhuman Primates","volume":"4","author":"Oppler","year":"2023","journal-title":"Surgeries"},{"key":"10.1016\/j.ymthe.2025.07.007_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biology11030423","article-title":"Behavioral Management as a Coping Strategy for Managing Stressors in Primates: The Influence of Temperament and Species","volume":"11","author":"Palmer","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.ymthe.2025.07.007_bib76","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1600-0684.2011.00525.x","article-title":"Successful implementation of cooperative handling eliminates the need for restraint in a complex non-human primate disease model","volume":"41","author":"Graham","year":"2012","journal-title":"J. Med. Primatol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500543X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500543X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:48:28Z","timestamp":1792788508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500543X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S152500162500543X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.007","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}